{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:47:47Z","timestamp":1793724467039,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jocn.2024.04.015","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T16:13:30Z","timestamp":1713284010000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Ki-67 index as a predictive marker of meningioma recurrence following surgical resection"],"prefix":"10.1016","volume":"124","author":[{"given":"Mark","family":"Mizrachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzaib","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonah","family":"Ziemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Goenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.04.015_b0005","doi-asserted-by":"crossref","unstructured":"Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma. Neurosurgery 2005;57:1088\u201395; discussion 1088-1095. https:\/\/doi.org\/10.1227\/01.neu.0000188281.91351.b9.","DOI":"10.1227\/01.NEU.0000188281.91351.B9"},{"key":"10.1016\/j.jocn.2024.04.015_b0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0090-3019(87)90005-X","article-title":"Incidental meningiomas in autopsy study","volume":"27","author":"Nakasu","year":"1987","journal-title":"Surg Neurol"},{"key":"10.1016\/j.jocn.2024.04.015_b0015","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015. Neuro-Oncology 2018;20:iv1\u201386. https:\/\/doi.org\/10.1093\/neuonc\/noy131.","DOI":"10.1093\/neuonc\/noy131"},{"key":"10.1016\/j.jocn.2024.04.015_b0020","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2024.04.015_b0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1227\/01.NEU.0000330399.55586.63","article-title":"Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation","volume":"64","author":"Aghi","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2024.04.015_b0030","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4065\/73.10.936","article-title":"Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988","volume":"73","author":"Stafford","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jocn.2024.04.015_b0035","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.2007.121582","article-title":"Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features","volume":"79","author":"Yang","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2024.04.015_b0040","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3171\/jns.1997.86.5.0793","article-title":"Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases","volume":"86","author":"Palma","year":"1997","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2024.04.015_b0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fonc.2013.00227","article-title":"Radiation Treatment for WHO Grade II and III Meningiomas","volume":"3","author":"Walcott","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2024.04.015_b0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: From the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jocn.2024.04.015_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910310104","article-title":"Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation","volume":"31","author":"Gerdes","year":"1983","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jocn.2024.04.015_b0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/02688698909001031","article-title":"The Implications of the Heterogeneous Distribution of Ki-67 Labelled Cells in Meningiomas","volume":"3","author":"Siegers","year":"1989","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.jocn.2024.04.015_b0065","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jclinpath-2012-201085","article-title":"Ki67 and proliferation in breast cancer","volume":"66","author":"Pathmanathan","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jocn.2024.04.015_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-008-0081-7","article-title":"The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer","volume":"116","author":"Jones","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jocn.2024.04.015_b0075","first-page":"2298","article-title":"Prognostic value of Ki67 index in gastrointestinal stromal tumors","volume":"7","author":"Zhao","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jocn.2024.04.015_b0080","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1200\/JCO.2004.09.150","article-title":"Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy Oncology Group Trial 92\u201302","volume":"22","author":"Pollack","year":"2004","journal-title":"JCO"},{"key":"10.1016\/j.jocn.2024.04.015_b0085","doi-asserted-by":"crossref","first-page":"44281","DOI":"10.1038\/srep44281","article-title":"Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis","volume":"7","author":"Xie","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2024.04.015_b0090","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/sj.bjc.6601453","article-title":"The Ki67 index a prognostic marker in medullary thyroid carcinoma","volume":"89","author":"Tisell","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jocn.2024.04.015_b0095","doi-asserted-by":"crossref","first-page":"e0158891","DOI":"10.1371\/journal.pone.0158891","article-title":"Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2024.04.015_b0100","doi-asserted-by":"crossref","first-page":"17918","DOI":"10.1038\/s41598-021-95958-9","article-title":"Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells","volume":"11","author":"Dahlrot","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2024.04.015_b0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3171\/jns.1997.86.1.0121","article-title":"Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value","volume":"86","author":"Cunningham","year":"1997","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2024.04.015_b0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF00296379","article-title":"Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study","volume":"81","author":"Louis","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jocn.2024.04.015_b0115","doi-asserted-by":"crossref","first-page":"e18644","DOI":"10.1097\/MD.0000000000018644","article-title":"The prognostic role of Ki-67\/MIB-1 in meningioma","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jocn.2024.04.015_b0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.21873\/anticanres.14766","article-title":"Combination of p53 and Ki67 as a Promising Predictor of Postoperative Recurrence of Meningioma","volume":"41","author":"Nagahama","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jocn.2024.04.015_b0125","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/neuros\/nyaa226","article-title":"The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma","volume":"87","author":"Mirian","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2024.04.015_b0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11060-020-03688-1","article-title":"Resected WHO grade I meningioma and predictors of local control","volume":"152","author":"Nowak-Choi","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.04.015_b0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40478-022-01377-w","article-title":"Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index","volume":"10","author":"Teranishi","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jocn.2024.04.015_b0140","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1177\/0962280216680383","article-title":"The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation","volume":"27","author":"Hajian-Tilaki","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jocn.2024.04.015_b0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2024.04.015_b0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3171\/jns.1983.58.1.0051","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"58","author":"Adegbite","year":"1983","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2024.04.015_b0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","article-title":"Meningioma: analysis of recurrence and progression following neurosurgical resection","volume":"62","author":"Mirimanoff","year":"1985","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2024.04.015_b0160","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jocn.2024.04.015_b0165","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","article-title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","volume":"54","author":"Choudhury","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2024.04.015_b0170","doi-asserted-by":"crossref","first-page":"e12970","DOI":"10.1111\/bpa.12970","article-title":"Prognostic impact of genetic alterations and methylation classes in meningioma","volume":"32","author":"Berghoff","year":"2022","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jocn.2024.04.015_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clineuro.2017.05.002","article-title":"Genetic and epigenetic alterations in meningiomas","volume":"158","author":"Galani","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jocn.2024.04.015_b0180","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/532451","article-title":"Epigenetics of meningiomas","volume":"2015","author":"Murny\u00e1k","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jocn.2024.04.015_b0185","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jocn.2024.04.015_b0190","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1038\/sj.onc.1205419","article-title":"TERT regulates cell survival independent of telomerase enzymatic activity","volume":"21","author":"Cao","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jocn.2024.04.015_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bpa.12892","article-title":"TERT promoter mutations in primary and secondary WHO grade III meningioma","volume":"31","author":"Maier","year":"2021","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jocn.2024.04.015_b0200","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jocn.2024.04.015_b0205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2017.168","article-title":"Advances in meningioma genetics: novel therapeutic opportunities","volume":"14","author":"Preusser","year":"2018","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682400153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682400153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T04:42:51Z","timestamp":1749357771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758682400153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"alternative-id":["S096758682400153X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.04.015","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ki-67 index as a predictive marker of meningioma recurrence following surgical resection","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}